Analysts: Walgreens May Benefit from Boots Acquisition and 3 Other Research Notes to Look Over

Walgreens (NYSE:WAG):Ā Barrington upgraded Walgreens to Outperform from Market Perform with a $65 price target, citing managementā€™s execution of the Boots acquisition. The firm says that the synergy targets are ahead of expectations.

WAG 20131003